Technology News and Research

RSS

Researchers find new way to prevent blindness caused by retinitis pigmentosa

Researchers at the University of Oklahoma Health Sciences Center have found a way to use a radical new type of gene therapy to prevent blindness caused by retinitis pigmentosa, giving hope to the estimated 100,000 Americans who suffer from this debilitating disease.

14 Jun 2010

Allied Telesis to provide integrated network solutions for TAF hospital system

Allied Telesis, Inc., a global provider of secure IP/Ethernet switching solutions and an industry leader in the deployment of converged multi-play networks, was selected by the Turkish Armed Forces (TAF), the second-largest standing force in the North Atlantic Treaty Organization (NATO), as the network solutions provider for improvements to 34 military medical facilities as part of an ongoing technology modernization effort driven by the Turkish Ministry of Defense.

14 Jun 2010

Researchers discover key factor in beading mechanism

Researchers at Rice University, Purdue University and the Massachusetts Institute of Technology have solved a long-standing mystery about why some fluids containing polymers -- including saliva -- form beads when they are stretched and others do not.

14 Jun 2010

Despite economic downturn, NJ biotechnology industry continues to grow

The number of biotechnology companies operating in New Jersey continues to increase significantly despite the downturn in the economy, ongoing difficulties in obtaining venture capital and other forms of funding and a contraction in the biotechnology and pharmaceutical industries at both the state and national levels, according to initial results from an industry survey released today by BioNJ, the trade association for the biotechnology industry in New Jersey.

14 Jun 2010

3M Health Care launches new foam adhesive dressings for acute and chronic wounds

3M Health Care today announced the introduction of a full line of new, innovative Tegaderm™ High Performance Foam Adhesive Dressings. In clinical and laboratory tests, these new adhesive foam wound dressings outperform other leading foam adhesive dressings in managing the full range of low- to high-moisture conditions that can be present in chronic and acute wounds.

14 Jun 2010

Genetic variation can predict how people infected with hepatitis C react to treatment: Scientists

A small genetic change can predict how people infected with hepatitis C react to treatment, paving the way to personalised therapy for this difficult to treat disease, the annual conference of the European Society of Human Genetics will hear today (Sunday 13 June). Dr. Zoltan Kutalik, from the Department of Medical Genetics, University of Lausanne, Switzerland, will tell delegates that individuals with this change, in a gene encoding for the antiviral cytokine (cell-signalling molecule) interferon lamda, reacts less well to treatment.

14 Jun 2010

Chiasma successfully completes Phase I clinical study of Octreolin

Chiasma, Inc., a privately held biopharma company, announced that it has successfully completed a Phase I clinical study evaluating the safety and pharmacokinetics (PK) of its proprietary product Octreolin, which contains the active ingredient octreotide actetate and is administered orally

14 Jun 2010

BIOTECanada congratulates CPHA on 100 years of leadership in public health

As a community partner of the Canadian Public Health Association, BIOTECanada, on behalf of Canada's biotechnology industry, congratulates the CPHA on 100 years of leadership in public health.

11 Jun 2010

Equatorial Guinea advances public health services with ultramodern hospital in Bata

Equatorial Guinea (Republica de Guinea Ecuatorial) is advancing its public health services with an ultramodern hospital in Bata, the country's most populous city. One of the most sophisticated hospitals in West Africa, La Paz Medical Center operates in complete compliance with international standards and employs highly advanced technology systems.

11 Jun 2010

ACT's hESC line MA135 approved for federal funding

Advanced Cell Technology, Inc. announced today that human embryonic stem cell line MA135 was unanimously approved for federal funding at the 100th Meeting of the Advisory Committee to the Director National Institutes of Health. In addition to MA135, seven additional stem cell lines derived at ACT are currently under review by the NIH.

11 Jun 2010

Start-up seeks to provide consumers with health care comparison shopping guide

The New York Times: In the U.S., people generally compare prices on everything from groceries to cars, but not in regard to their health care. And even if patients wanted to be health care comparison shoppers, getting the necessary information is not easy.

11 Jun 2010

EHNAC announces second stage of public review and comment for its HIE Accreditation Program

The Electronic Healthcare Network Accreditation Commission, a non-profit standards development organization and accrediting body, today announced the second stage of public review and comment for its Health Information Exchange Accreditation Program. Compared to the first phase of the program's public review in February, which focused on privacy and security, technical performance, business practices and organizational resources, this second phase will explicitly address HIE-specific policies as developed by the HIE Advisory Board.

11 Jun 2010

NTI's standalone ePrescribing solution RxNT eRx achieves Gold Solution Provider status

Networking Technology, Inc., the leader in electronic healthcare technology, today announced that their standalone eprescribing software product received Gold Solution Provider status from Surescripts. NTI's standalone ePrescribing solution RxNT eRx has achieved Gold Solution Provider status placing their standalone eprescribing solution into an elite group of certified products for the fourth year in a row.

11 Jun 2010

Accident Fund Insurance wins ACORD Most Compelling Case Study Award

Accident Fund Insurance Company of America, a leading national workers compensation insurance company, was recently honored at the annual ACORD LOMA Insurance Systems Forum at the Mandalay Bay Resort in Las Vegas, NV. Accident Fund won a Most Compelling Case Study Award in the Property, Casualty & Surety Market category.

11 Jun 2010

Boston Scientific announces event schedule at 17th Cardiostim World Congress

Boston Scientific Corporation today announced the schedule of the Company's key events and sponsored research at the 17th Cardiostim World Congress, June 16 – 19 in Nice, France.

11 Jun 2010

Waismann Method survey: 88% of individuals taken prescription painkillers for chronic pain relief

According to a recent survey conducted by the Waismann Method of opiate detoxification, doctors prescribing medication for the treatment of chronic pain were found to be the leading source of prescription painkiller use. Approximately 88 percent of all respondents stated they began taking prescription painkillers for chronic pain relief, with an astounding 70 percent of these individuals believing that they experience the same or a greater amount of pain than when originally prescribed painkillers.

11 Jun 2010

PharmaTrust to demonstrate MedCenter technology at Annual Healthcare Conference

PharmaTrust has been invited to participate in the Private Company forum of the Goldman Sachs 31st Annual Healthcare Conference in Los Angeles, June 14th to 17th. The company will demonstrate its revolutionary Healthcare…Everywhere MedCenter which will connect conference 'patients' in Los Angeles to PharmaTrust pharmacists in Toronto.

11 Jun 2010

Cook Medical files for PMA of Zilver PTX Drug-Eluting Peripheral Stent with FDA

Cook Medical has submitted its Pre-Market Approval (PMA) application to the U.S. Food and Drug Administration (FDA) for the company's unique polymer-free Zilver® PTX® Drug-Eluting Peripheral Stent. Intended for use in patients with peripheral arterial disease (PAD) in the superficial femoral artery (SFA), Zilver PTX is a self-expanding, highly durable nitinol stent that uses a proprietary, polymer-free technology to deliver a locally therapeutic dose of paclitaxel, an antiproliferative drug, to the target lesion.

11 Jun 2010

Zargis Medical signs exclusive license agreement with Boston-based Stethographics

Zargis Medical Corp., a majority-owned subsidiary of Speedus Corp., today announced that it has entered into an agreement with Boston-based Stethographics, Inc. providing an exclusive license to patented, FDA-cleared Stethographics lung sounds analysis technology that automatically identifies clinically significant respiratory sounds.

11 Jun 2010

Interactions between human and microbial cells determine health, physical well-being: Researchers

At birth, your body was 100-percent human in terms of cells. At death, about 10-percent of the cells in your body will be human and the remaining 90-percent will be microorganisms. That makes you a "supraorganism," and it is the interactions between your human and microbial cells that go a long way towards determining your health and physical well-being, especially your resistance to infectious diseases.

11 Jun 2010

Technology News and Research

Researchers find new way to prevent blindness caused by retinitis pigmentosa

Allied Telesis to provide integrated network solutions for TAF hospital system

Researchers discover key factor in beading mechanism

Despite economic downturn, NJ biotechnology industry continues to grow

3M Health Care launches new foam adhesive dressings for acute and chronic wounds

Genetic variation can predict how people infected with hepatitis C react to treatment: Scientists

Chiasma successfully completes Phase I clinical study of Octreolin

BIOTECanada congratulates CPHA on 100 years of leadership in public health

Equatorial Guinea advances public health services with ultramodern hospital in Bata

ACT's hESC line MA135 approved for federal funding

Start-up seeks to provide consumers with health care comparison shopping guide

EHNAC announces second stage of public review and comment for its HIE Accreditation Program

NTI's standalone ePrescribing solution RxNT eRx achieves Gold Solution Provider status

Accident Fund Insurance wins ACORD Most Compelling Case Study Award

Boston Scientific announces event schedule at 17th Cardiostim World Congress

Waismann Method survey: 88% of individuals taken prescription painkillers for chronic pain relief

PharmaTrust to demonstrate MedCenter technology at Annual Healthcare Conference

Cook Medical files for PMA of Zilver PTX Drug-Eluting Peripheral Stent with FDA

Zargis Medical signs exclusive license agreement with Boston-based Stethographics

Interactions between human and microbial cells determine health, physical well-being: Researchers

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News